PMS19 FRACTURE-RELATED TREATMENT COSTS ATTRIBUTABLE TO PROTON PUMP INHIBITOR USE IN OSTEOPOROSIS PATIENTS
May 1, 2011, 00:00 AM
10.1016/j.jval.2011.02.704
https://www.valueinhealthjournal.com/article/S1098-3015(11)00843-6/fulltext
Section Title :
Disease-Specific Studies
Section Order :
162
First Page :
A126
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00843-6&doi=10.1016/j.jval.2011.02.704